Global Market Access Strategy

Client Type A late-stage clinical biopharma company
Function Development of country‑level market access roadmaps using pricing/access analogue assessment for a cardiology rare disease asset.
Challenge Global pricing and access strategy
Impact Reimbursement strategy and launch planning informed

Challenge

A late-stage clinical biopharma company needed support to develop a global market access strategy for its cardiology rare disease asset. They wanted to conduct a pricing and access analogue assessment to determine an appropriate access and pricing strategy.

Approach

Scimitar reviewed pre-existing research across opportunity assessment, pricing, and brand strategic plans to determine criteria for assessment. We leverage the content to collaborate with internal stakeholders to create country-specific launch plans and access roadmaps.

Impact

Generated deliverables contributed to key actions and timing to execute reimbursement strategy and launch planning efforts.

Talk through a similar challenge.

Facing a version of this problem? Bring it to a conversation and we will walk through what it would take to make the change real.

Schedule a Conversation
Explore More Proof

Related Case Studies

See All Case Studies